封面
市場調查報告書
商品編碼
1699073

靈芝市場成長、規模和趨勢分析:按性質和用途 - 區域展望、競爭策略和細分預測(截至 2034 年)

Reishi Mushroom Market Growth, Size, Trends Analysis - By Nature, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 272 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年靈芝市場規模將達到 223.3 億美元,複合年成長率為 12.29%。

靈芝因其藥用特性而受到廣泛重視,包括支持免疫系統、抗發炎作用和潛在的抗癌特性。這些好處使得靈芝成為醫療用品中的常見成分。靈芝用於多種藥物製劑,包括膠囊、錠劑和萃取物,以提供所需的健康益處。

儘管靈芝越來越受歡迎,但仍存在一些挑戰阻礙其市場成長。主要障礙之一是生產成本高,這可能會限制靈芝產品的供應和可負擔性,尤其是對於低收入消費者而言。此外,不同供應商的品質差異和污染的可能性可能會引發對產品安全的擔憂並削弱消費者信心。

本報告調查了全球靈芝市場,並提供了市場概況摘要、市場影響因素和市場機會分析、市場規模趨勢和預測、各個細分市場、地區/主要國家的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場動態

  • 促進因素、阻礙因素、機會與挑戰分析

第5章 市場變數與展望

  • SWOT分析
  • PESTEL分析
  • 波特五力分析
  • 熱圖分析

第6章 競爭格局

  • 製造地、銷售區域、產品類型分佈
  • 併購、合作夥伴關係、產品發布和合作

7. 靈芝市場按類型

  • 有機的
  • 常規產品

第8章 靈芝市場應用分析

  • 製藥
  • 營養補充品
  • 化妝品

第9章 靈芝蘑菇市場

  • 靈芝市場規模與市場佔有率

第10章 靈芝市場區域分佈

  • 亞太地區
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 埃及
    • 摩洛哥
    • 奈及利亞
    • 其他
  • 北美洲
    • 加拿大
    • 墨西哥
    • 美國
  • 拉丁美洲
    • 阿根廷
    • 巴西
    • 其他

第11章 公司簡介

  • Alphay International Inc.
  • Bio-Botanica
  • Bristol Botanicals Limited
  • DXN Holdings Bhd
  • Hokkaido Reishi
  • Hokkaido Reishi Co., Ltd.
  • Mushroom Science
  • Nammex (North American Medicinal Mushroom Extracts)
  • 其他

第12章結論

第13章簡稱表

第 14 章參考鏈接

簡介目錄
Product Code: FOOD2531

Reishi Mushroom Market Introduction and Overview

According to SPER market research, 'Reishi Mushroom Market Size- By Nature, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Reishi Mushroom Market is predicted to reach 22.33 billion by 2034 with a CAGR of 12.29%.

Reishi mushrooms are widely valued for their medical characteristics, which include immune system support, anti-inflammatory benefits, and potential anti-cancer activity. These advantages make them a common component in therapeutic goods. Reishi mushrooms are used in a variety of medicinal formulations, including capsules, pills, and extracts, in order to deliver targeted health advantages.

Restraints: Despite the growing popularity of reishi mushrooms, several issues are hindering market growth. One major hurdle is the expensive cost of production, which can limit the affordability and availability of reishi-based products, especially for low-income consumers. Furthermore, inconsistencies in quality across suppliers and the likelihood of contamination may cause concerns about product safety, diminishing consumer trust.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Nature, By Application.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered Alphay International Inc., Bio-Botanica, Bristol Botanicals Limited, DXN Holdings Bhd, Hokkaido Reishi, Hokkaido Reishi Co., Ltd., Mushroom Science, Nammex (North American Medicinal Mushroom Extracts).

Reishi Mushroom Market Segmentation:

By Nature: Based on the Nature, Reishi Mushroom Market is segmented as; Organic, Conventional.

By Application: Based on the Application, Reishi Mushroom Market is segmented as; Pharmaceutical, Dietary Supplements, and Cosmetics.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPERs internal database
    • 2.1.4. Premium insight from KOLs
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTERs Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Reishi Mushroom Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Reishi Mushroom Market

7. Reishi Mushroom Market, By Nature 2021-2034 (USD Million)

  • 7.1. Organic
  • 7.2. Conventional

8. Reishi Mushroom Market, By Application 2021-2034 (USD Million)

  • 8.1. Pharmaceutical
  • 8.2. Dietary Supplements
  • 8.3. Cosmetics

9. Reishi Mushroom Market, 2021-2034 (USD Million)

  • 9.1. Reishi Mushroom Market Size and Market Share

10. Reishi Mushroom Market, By Region, 2021-2034 (USD Million)

  • 10.1. Asia Pacific
    • 10.1.1. Australia
    • 10.1.2. China
    • 10.1.3. India
    • 10.1.4. Japan
    • 10.1.5. South Korea
  • 10.2. Europe
    • 10.2.1. France
    • 10.2.2. Germany
    • 10.2.3. Italy
    • 10.2.4. Spain
    • 10.2.5. United Kingdom
    • 10.2.6. Rest of Europe
  • 10.3. Middle East and Africa
    • 10.3.1. Kingdom of Saudi Arabia
    • 10.3.2. U.A.E
    • 10.3.3. Qatar
    • 10.3.4. South Africa
    • 10.3.5. Egypt
    • 10.3.6. Morocco
    • 10.3.7. Nigeria
    • 10.3.8. Rest of Middle-East and Africa
  • 10.4. North America
    • 10.4.1. Canada
    • 10.4.2. Mexico
    • 10.4.3. United States
  • 10.5. Latin America
    • 10.5.1. Argentina
    • 10.5.2. Brazil
    • 10.5.3. Rest of Latin America

11. Company Profile

  • 11.1. Alphay International Inc.
    • 11.1.1. Company details
    • 11.1.2. Financial outlook
    • 11.1.3. Product summary
    • 11.1.4. Recent developments
  • 11.2. Bio-Botanica
    • 11.2.1. Company details
    • 11.2.2. Financial outlook
    • 11.2.3. Product summary
    • 11.2.4. Recent developments
  • 11.3. Bristol Botanicals Limited
    • 11.3.1. Company details
    • 11.3.2. Financial outlook
    • 11.3.3. Product summary
    • 11.3.4. Recent developments
  • 11.4. DXN Holdings Bhd
    • 11.4.1. Company details
    • 11.4.2. Financial outlook
    • 11.4.3. Product summary
    • 11.4.4. Recent developments
  • 11.5. Hokkaido Reishi
    • 11.5.1. Company details
    • 11.5.2. Financial outlook
    • 11.5.3. Product summary
    • 11.5.4. Recent developments
  • 11.6. Hokkaido Reishi Co., Ltd.
    • 11.6.1. Company details
    • 11.6.2. Financial outlook
    • 11.6.3. Product summary
    • 11.6.4. Recent developments
  • 11.7. Mushroom Science
    • 11.7.1. Company details
    • 11.7.2. Financial outlook
    • 11.7.3. Product summary
    • 11.7.4. Recent developments
  • 11.8. Nammex (North American Medicinal Mushroom Extracts)
    • 11.8.1. Company details
    • 11.8.2. Financial outlook
    • 11.8.3. Product summary
    • 11.8.4. Recent developments
  • 11.9. Others

12. Conclusion

13. List of Abbreviations

14. Reference Links